Mathieu Simon

Dr. Mathieu Simon is a Chairman at Epsilen Bio SRL, a Chairman at Idorsia Ltd., an Independent Director at Asarina Pharma AB, an Independent Director at Vaximm AG, a Chairman at Idorsia Pharmaceuticals Ltd., a Chief Executive Officer at Cellectis Therapeutics and an Independent Director at LNC Therapeutics SA. He is on the Board of Directors at Lysogene SA, Asarina Pharma AB, Affimed NV, Affimed GmbH, Vaximm AG, Messier Maris & Associés SCA and LNC Therapeutics SA. Dr. Simon was previously employed as an EVP, Chief Operating & Medical Officer by Cellectis SA, a Vice President-Marketing & Medical Affairs by Wyeth Pharmaceuticals LLC, a Group VP-Marketing & Clinical Affairs by Wyeth-Ayerst International, Inc., a Senior Vice President-Global Operations by Pierre Fabre Médicament SAS, a Managing Director & Head-Global Pharma by Pierre Fabre SA, and a Chairman & Chief Executive Officer by Takara Bio Europe AB. He also served on the board at Alliance for Regenerative Medicine, Ectycell SASU and Farmindustria.